
BDTX
USDBlack Diamond Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$3.850
High
$3.860
Low
$3.620
Volume
0.96M
Company Fundamentals
Market Cap
206.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.92M
Exchange
NMS
Currency
USD
52-Week Range
Related News
HC Wainwright & Co. Maintains Buy on Black Diamond Therapeutic, Lowers Price Target to $10
HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic with a Buy and lowers the price target from $12 to $10.
Black Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Enrollment completed for the Phase 2 trial of silevertinib (BDTX-1535) in 1L patients with non-classical EGFRm NSCLC (n=43); ORR and preliminary DOR data on track for Q4 2025Exploring partnership opportunities to advance
Related Stocks
COIN
Coinbase Global Inc.
YORW
York Water Company (The)
DECAW
Denali Capital Acquisition Corp. Warrant
RMCO
Royalty Management Holding Corporation
BSTZ
BlackRock Science and Technology Term Trust Common Shares of Beneficial Interest
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.